BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14981968)

  • 21. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
    Awaya H; Takeshima Y; Yamasaki M; Inai K
    Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content.
    Nakayama H; Noguchi M; Tsuchiya R; Kodama T; Shimosato Y
    Mod Pathol; 1990 May; 3(3):314-20. PubMed ID: 2362938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cyclooxygenase-2 in adenocarcinomas of the uterine cervix and its relation to angiogenesis and tumor growth.
    Lee JS; Choi YD; Lee JH; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Kim HS; Min KW
    Gynecol Oncol; 2004 Dec; 95(3):523-9. PubMed ID: 15581957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression.
    Kerr KM; Carey FA; King G; Lamb D
    J Pathol; 1994 Dec; 174(4):249-56. PubMed ID: 7884586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging.
    Maitra A; Ashfaq R; Gunn CR; Rahman A; Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Wilentz RE
    Am J Clin Pathol; 2002 Aug; 118(2):194-201. PubMed ID: 12162677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung. A study of 117 patients from Brazil.
    Yamaguchi NH; Lichtenfels AJ; Demarchi LM; da Silva AP; Garippo AL; Alves VF; Michelin C; Azevedo PM; Moya T; Takagaki T; Saldiva PH; Vollmer RT; Capelozzi VL
    Am J Clin Pathol; 2004 Jan; 121(1):78-86. PubMed ID: 14750244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung.
    Mori M; Rao SK; Popper HH; Cagle PT; Fraire AE
    Mod Pathol; 2001 Feb; 14(2):72-84. PubMed ID: 11235908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms.
    Ruffini E; Bongiovanni M; Cavallo A; Filosso PL; Giobbe R; Mancuso M; Molinatti M; Oliaro A
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):165-72. PubMed ID: 15200997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclooxygenase-2 expression in human gastric tubular adenomas and carcinomas; correlation with intratumoral microvessel density and apoptotic index.
    Honjo S; Kase S; Osaki M; Ardyanto TD; Kaibara N; Ito H
    Anticancer Res; 2004; 24(3a):1439-44. PubMed ID: 15274307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of cyclooxygenase-2,and matrix metalloproteinase-2 expression on prognosis of lung cancer].
    Zhang HZ; Lu ZQ; Xie DR; Li HG; Xiong LH; Zhang H; Chen XB
    Ai Zheng; 2004 Oct; 23(10):1190-3. PubMed ID: 15473933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma.
    Awaya H; Takeshima Y; Amatya VJ; Ishida H; Yamasaki M; Kohno N; Inai K
    Pathol Int; 2005 Jan; 55(1):14-8. PubMed ID: 15660698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expressions of claudin 4 and 7 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
    Yamada G; Murata M; Takasawa A; Nojima M; Mori Y; Sawada N; Takahashi H
    Med Mol Morphol; 2016 Sep; 49(3):163-9. PubMed ID: 26872891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear factor-kappa B regulates cyclooxygenase-2 expression and cell proliferation in human colorectal carcinoma tissue.
    Yu LL; Yu HG; Yu JP; Luo HS
    Eksp Onkol; 2004 Mar; 26(1):40-7. PubMed ID: 15112579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer.
    Byun JH; Lee MA; Roh SY; Shim BY; Hong SH; Ko YH; Ko SJ; Woo IS; Kang JH; Hong YS; Lee KS; Lee AW; Park GS; Lee KY
    Jpn J Clin Oncol; 2006 May; 36(5):263-8. PubMed ID: 16735371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2 expression in brain metastases.
    Karim A; Fowler M; Jones L; Patwardhan R; Vannemreddy P; Mccarthy K; Nanda A
    Anticancer Res; 2005; 25(4):2969-71. PubMed ID: 16080553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients.
    Erdoğan B; Uzaslan E; Budak F; Karadağ M; Ediger D; Oral B; Göral G; Ege E; Gözü O
    Tuberk Toraks; 2005; 53(2):127-31. PubMed ID: 16100648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the expression of Fas, FasL and Bcl-2 in the pathogenesis of autoimmune thyroid disorders.
    Chen S; Fazle Akbar SM; Zhen Z; Luo Y; Deng L; Huang H; Chen L; Li W
    Cell Mol Immunol; 2004 Jun; 1(3):224-8. PubMed ID: 16219172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients.
    Shimizu M; Kondo M; Ito Y; Kume H; Suzuki R; Yamaki K
    Cancer Detect Prev; 2005; 29(2):175-80. PubMed ID: 15829378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas.
    Niijima M; Yamaguchi T; Ishihara T; Hara T; Kato K; Kondo F; Saisho H
    Cancer; 2002 Mar; 94(5):1565-73. PubMed ID: 11920515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
    Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
    Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.